Santineoplastic potential of medicinal plants

Recent Patents on Biotechnology

Volumn 5, Issue 2, 2011, Pages 85-94

  Shynu, M ^a   Gupta, K P ^a   Saini, M ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Anticancer; Antineoplastic; Cancer; Extracts; Herbs; In vitro; Medicinal plants

Indexed keywords

DISEASES; DRUG INTERACTIONS; PLANT EXTRACTS;

ANTICANCER; ANTICANCER DRUG; ANTINEOPLASTIC; CANCER; DEVELOPED COUNTRIES; EXTRACT; HERB; IN-VITRO; MEDICINAL PLANTS; PLANT ORIGIN;

CHEMOTHERAPY;

ALKALOID; ANDROGRAPHOLIDE; ANTINEOPLASTIC AGENT; AVICIN; BETULIC ACID; CHINESE DRUG; CRANBERRY EXTRACT; CURCUMIN; CYTOTOXIC AGENT; DAURINOL; ETOPOSIDE; EURYCOMANONE; GARLIC EXTRACT; HERBACEOUS AGENT; IRINOTECAN; ISOLIQUIRITIGENIN; MYRICETIN; MYRMECODYA PENDENS EXTRACT; NOSCAPINE; PACLITAXEL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; TENIPOSIDE; TOPOTECAN; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; WITHAFERIN A; FOOD ADDITIVE; TUMOR SUPPRESSOR PROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CHILDHOOD LEUKEMIA; COLORECTAL CANCER; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; ERRATUM; EXPERIMENTAL NEOPLASM; HERBAL MEDICINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LUNG SMALL CELL CANCER; MEDICINAL PLANT; MELANOMA; METASTASIS; MYRMECODYA PENDENS; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PATENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; NEOPLASM; ONCOGENE; PATHOLOGY; PHYTOTHERAPY; POLLUTANT; REVIEW;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; ENVIRONMENTAL POLLUTANTS; FOOD ADDITIVES; HUMANS; NEOPLASMS; ONCOGENES; PATENTS AS TOPIC; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; TUMOR SUPPRESSOR PROTEINS;

EID: 79960573444     PISSN: 18722083     EISSN: None     Source Type: Journal    
DOI: 10.2174/187220811796365662     Document Type: Erratum

References (127)

1. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Joanna, M, Jane, D. (2001) Pathogenesis and tumour biology. In: Small Animal Oncology, Blackwell Publishers, pp. 7-13.
3. Cullem J M, Page R and Misdorp W, 2002, An overview of cancer pathogenesis, diagnosis and management. In: Tumors in Domestic Animals, Donald, J. M. (Eds), IV Ed. Iowa State Press, pp. 14-15.
4. Calabresi P, Chabner B A in Hardman J G, Limbird L E, Eds. Goodman and Gilman's. The Pharmacological Basis of Therapeutics. Mc Graw Hill: Medical Publishing Division 2001:1381-88.
5. Shoeb M. Anticancer agents from medicinal plants. Bangladesh J Pharmacol. 2006; 1: 35-41.
6. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985; 63: 965-81.
7. Butlet MS. The role of natural product chemistry in drug discovery. J Nat. Prod. 2004; 67: 2141-53.
8. Oberlines NH, Kroll DJ. Camptothecins and taxol: historic achievement in natural products research. J Nat. Prod. 2004; 67: 129-35.
9. Newman, DJ. Natural products as a source of new drugs over the period 1981-2002. J. Nat. Prod. 2003; 66: 1002-37.
10. Free MJ. Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. Chem. Inf. Comput. Sci. 2003; 43: 218-27.
11. Taylor LND. Available at http://www.rain-tree.com/plantdrugs.htm. (Accessed on 22nd November, 2010).
12. Straubinger RM, Sharma A, Mayhew E. Taxol Formulation. EP0683664, 2000.
13. Wilson W, Wittes R E. Taxol treatment for breast cancer.US5496846, 1996.
14. Wilson W, Wittes R E, Fojo A T, Bates S. Taxol treatment for breast cancer. RE40839, 2009.
15. Hu L, Shen Xu, Jiang H, Lou L. Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives. US 20100113498, 2010.
16. Schmidt B, Kutney J, Mayer L. Anhydrovinblastine for the treatment of cancer. US20020103218, 2002.
17. Schmidt B, Kutney J, Mayer L. Anhydrovinblastine for the treatment of cancer. US20030162803, 2003.
18. VJ.Vincristine-containing product. US5055449, 1991.
19. Wilson WR, Siim B G. Anti-cancer combinations. US20080070849, 2008.
20. Wilson WR, Siim B G. Anti-cancer combinations. US20040204480, 2004.
21. Gazdag M, Szepesi G, Nagy T, et al. Stable parenteral compositions of vinblastine or vincristine. US5397784, 1995.
22. Sarris AH, Cabanillas F, Logan PM. Compositions and methods for treating lymphoma. US20040228909, 2004.
23. Dell'orco PC, Diederich AM, Su QW, Jeffery L. Novel compound, corresponding compositions, preparation and/or treatment methods. US20100210677, 2010.
24. Jani JP, Beebe JS, Schaeffer TL, Healey DI, Ferrante KJ, O'leary JJ. Combination therapy for hyperproliferative disease. US20070197517, 2007.
25. Rahman A, Ahmad I. Liposomal formulation of irinotecan. US20050019387, 2005.
26. Bissery MC, Chiron-blondel M, Lejeune P, Vrignaud P. Antitumour combinations containing a VEGF inhibiting agent and irinotecan. US20100160233, 2010.
27. Miller LL, Emanuel D, Mcgovren J P, Schaaf L J, Ramachandra S. Method comprising irinotecan for treatment of breast cancer. US20040266704, 2004.
28. Lee K, Wang ZO, Bowen PJ, et al. Etoposide analogues. US5132322, 1992.
29. Crooks PA, Alonso R. Method for treatment for cancer. US20060009468, 2006.
30. Wang H, Haridas V, Gutterman JU, Xu ZX. Natural triterpenoid avicins selectively induce tumor cell death. Commun Integr Biol.2010; 3(3): 205-8.
31. Zakaria Y, Rahmat A, Pihie AH, Abdullah NR, Houghton PJ. Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53. Cancer Cell Int. 2009; 9:16.
32. Elliott M Jr, Chithan K, Theoharis C T. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer, Pharmacol Rev. 2000; 52(4): 673-751.
33. Lines T C. Quercetin-Containing Compositions. US20100160245, 2010.
34. Young C, Xing N. Methods and compositions for inhibiting the proliferation of prostate cancer cells. US20030054357, 2003.
35. Jun L, Laura V P, Jianguo F Salvador RN, Boris Z, Arne H. Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity. Cancer Res 2006; 66(8): 4410-18.
36. Mohan R, Hammers RJ, Bargagna-Mohan P, et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis, 2004; 7(2):115-22.
37. Koduru S, Kumar R, Srinivasan S, Evers MB, Damodaran C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther 2010; 9(1):202-10.
38. Samadi AK, Mukerji R, Shah A, Timmermann BN, Cohen MS. A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo. Surgery. 2010; 148(6):1228-36.
39. Takahashi T, Takasuka N, Iigo M, et al. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 2004; 95(5):448-53.
40. Chen S. Botanical extracts composition with anticancer activity comprising isoliquiritigenin. EP1487434, 2007.
41. Sarah P, Richard DV, Kirsti H. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/_ mouse, a model of familial adenomatous polyposis. Cancer Epidemiology, Biomarkers & Prevention. 2002; 11: 535-40.
42. Vander JDL, Deck LM, Abcouwer SF, Bobrovnikova-marjon E, Weber WM. Cancer treatment using curcumin derivatives. US20060276536, 2006.
43. Kurzrock R, Li L, Mehta K, Aggarawal BB. Liposomal curcumin for treatment of cancer. US 20060067998, 2006.
44. Jianguo F, Jun L, Arne H. Thioredoxin reductase is irreversibly modified by curcumin- A novel molecular mechanism for its anticancer activity. J Biol. Chem. 2005; 280(26): 25284-90.
45. Aneja R, Joshi HC, Vandapandu SN. Noscapine analogs and their use in treating cancers, including drug-resistant cancers. WO2008109609, 2008.
46. Nho CW, Kang KS, Lee SB, Dulamjav B, Jigjidsuren T. A pharmaceutical composition containing daurinol for the prevention and treatment of cancers. WO2008146989, 2009.
47. Debatin K M, Fulda S, Wiessler M, Los M, Mier W. Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor. US6369109, 2002.
48. D'arrigo C. Antineoplastic drug of plant extraction and process for the preparation thereof. WO 1993004689, 1993.
49. Romanczyk Jr. L F D J, Hammerstone Jr. J F, Buck M M. Antineoplastic cocoa extracts, methods for making, using. EP0789568, 2006.
50. Lin S, Harn H, Method for extracting antineoplastic components from Bupleurum scorzonerifolium. US7348032, 2008.
51. Astha V, Harish P, Neeta S. Andrographolide: A new plant-derived antineoplastic entity on horizon. eCAM; 2009: 1-9.
52. Nanduri S, Rajagopal S, Pothukuchi S, Pillai SBK, Chakrabarti R. Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them. US20020032229, 2002.
53. Benhamou N, Couture S. Garlic extract compositions, uses and preparations thereof. US 20080260876, 2008.
54. C. Acaricidal composition and use thereof in disinfesting treatments.US5227162, 1993.
55. Ohnishi T. Therapeutic uses of specially processed garlic for sickle cell disease. US6254871, 2001.
56. Cheon J, Kim J, Lee J, Kim H, Moon D. Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers. US6465020, 2002.
57. Annu A, Imtiaz A S, and Yogeshwer S. Modulation of p53 in 7,12-dimethylbenz[a]anthracene- induced skin tumors by diallyl sulphide in Swiss albino mice. Mol Cancer Ther 2004; 3(11): 1459-66.
58. Jingang S, Yunlong F, Chenghai Z, Wenxian P. Use of garlic oil to increase bioavailability of Coenzyme Q-10. US20090143484, 2009.
59. Vernon LP. Thionin as an antineoplastic and immunostimulant. WO2002022159, 2002.
60. Rao JM, Srinivas PV, Yadav JS, et al. A novel herbal chemical composition for the treatment of cancer. WO2003047608, 2008.
61. Kadota S, Nobukawa T. Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan. WO2004009065, 2004.
62. Mitra SK, Saxena E, Dixt MN, Uddagiri VB, Marikunt EVR, Mathad SA. Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof. WO2006134609, 2006.
63. Chu K H, Xie WD, Ho C Y. Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof.WO2008029136, 2008.
64. Banerjee S, Carlos B R, Aggarwal B B. Supprdession of 7, 12- Dimethylbenzanthracene induced mammary carcinogenesis in rats by resveratrol: Role of Nuclear Factor-Kb, cycloxygenase 2 and Matrix metalloprotease 9. Cancer Res 2002; 62: 4945-54.
65. Sardi W F. Resveratrol-containing compositions and their use in modulating gene product concentration or activity. US20090169585, 2009.
66. Shishir S, Harikumar KB, Dass S, Krishan GR and Aggarwal, BB.The Guggul for Chronic Diseases: Ancient Medicine, Modern Targets. Anticancer Res. 2008; 28 (6A): 3647-64.
67. Hongfen LI. An antineoplastic drug. EP1374880, 2006.
68. Gidekel M, Weber H, Cabrera G, et al. New extracts of Deschampsia antarctica desv. with antineoplastic activity. WO2009064480, 2009.
69. D'arrigo C. Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof. WO1992021359, 1992.
70. Alaoui-jamali MA, Ghadirian P. Antineoplastic extract from Achillea millefolium. WO2001013929, 2001.
71. Tjandrawinata RR, Aripin A, Arifin PF, Rahmi D. Extract of Phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent. WO2009153692, 2009.
72. Sekino Y. Anticancer compoition. US20100068317, 2010.
73. Djang AHK. Method for anticancer therapy using an herbal extract composition. US6168795, 2001.
74. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001; 480-481: 243-68.
75. R. Composition of eleven herbals for treating cancer. US6780441, 2004.
76. Solanki R. Herbal formulation. US20040009240, 2004.
77. Solanki R. Herbal formulation. US20030152585, 2003.
78. Solanki R. Herbal formulation. US6649185, 2003.
79. Liu J, Zhou J. Herb composition for treating lung cancer and preparation method thereof. US 7569234, 2005.
80. Liu J, Zhou J. Pharmaceuticals of chinese traditional medicine of treating lung cancer and preparation method thereof. WO2005058337, 2005.
81. Cheung DCL. Combined therapy with a herbal extract and a reovirus for killing neoplastic cells in a subject. WO2005112966, 2005.
82. Park JH, Lim MJ, Oh IS, et al. Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium. WO2009048306, 2009.
83. Lu E S, Young J. Herbal composition for treating cancer. WO2010028075, 2010.
84. Lombardo G, Malara D, Mollace V. Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field. WO2010055490, 2010.
85. Zacharia J. Method and preparation of herbal extract of Calotropis gigantea for cancer treatment. WO2008139483, 2008; & EP2152282, 2010.
86. Lowe H. Antitumor and anti-inflammatory extracts of plant biomass and their uses. US 7713556B2, 2010.
87. Soeksmanto A, Subroto MA, Wijaya H and Simanjuntak P. Anticancer activity test for extracts of sarang semut plant (Myrmecodya pendens) to HeLa and MCM-B2 cells. Pak J Biol Sci 2010; 13: 148-51.
88. CN. Cranberry and Its Photochemicals: A review of in vitro anticancer studies. J Nutr 2007; 137: 186S-193S.
89. Ozmen A, Bauer S, Gridling M, et al. In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey. Oncol Rep. 2009; 22(4):845-52.
90. Pratumvinit B, Srisapoomi T, Worawattananon P, Opartkiattikul N, Jiratchariyakul W and Kummalue T. In vitro antineoplastic effect of Ficus hispida L. plant against breast cancer cell lines. J. Med. Plants Res. 2009; 3(4):255-61.
91. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007; 109(2):177-206.
92. Rajeshkumar NV, Joy KL, Kuttan G, Ramsewak RS, Nair MG, Kuttan R. Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J Ethnopharmacol. 2002; 81(1):17-22.
93. Lin JY, Mach WB, Chen P. Pharmaceutical composition for inhibition of tumor growth or metastasis. US20060039999, 2006.
94. Matthew R, Chenguang W, Guang Y, Wei Z, Susan LJ. Protective effects of nexrutine, a Phellodendron amurense extract, against breast cancer is associated with autophagy. Cancer Prev Res 2008; 1(7 Suppl): A128.
95. Ooi KL, Tengku S T M, Shaida F S. Cytotoxic activities of Physalis minima l. chloroform extract on human lung adenocarcinoma NCI-H23 cell lines by induction of apoptosis, eCAM, 2009. Available at http://ecam.oxfordjournals.org (accessed on January 13, 2011)
96. Sur P, Ganguly DK. Tea plant root extract (TRE) as an antineoplastic agent. Planta Med. 1994; 60(2):106-9.
97. Sur P, Das M, Gomes A, et al. Trigonella foenum graecum (fenugreek) seed extract as an antineoplastic agent. Phytother Res 2001; 15:257-59.
98. Masud Rana AYKM and Khanam JA. Aristolochia indica whole plant extract as an antineoplastic agent. J Med Sci. 2002; 2: 202-5.
99. Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001; 75(2-3):65-9.
100. Guruvayoorappan C, Kuttan G. Immunomodulatory and antitumor activity of Biophytum sensitivum extract. Asian Pac J Cancer Prev. 2007; 8(1): 27-32.
101. Hedayati M, Yazdanparast R, Fasihi H, Azizi F. Anti-tumor activity of Daphne mucronata Extract and its effects on TNF-??. Pharmaceutical Biol. 2003;41(3): 194-198.
102. Bo L, He-jiao B, Jin-ku B. Plant lectins: Potential antineoplastic drugs from bench to clinic. Cancer Lett. 2010; 287(1): 1-12.
103. Noratto GD, Bertoldi MC, Krenek K, Talcott ST, Stringheta PC, Mertens-Talcott SU. Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties. J Agri Food Chem 2010; 58(7):4104-12.
104. Jagetia GC, Nayak V, Vidyasagar MS. Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells. Cancer Lett. 1998; 127(1-2): 71-82.
105. Cochrane CB, Nair PK, Melnick SJ, Resek AP, Ramachandran C. Anticancer effects of Annona glabra plant extracts in human leukemia cell lines. Anticancer Res. 2008; 28(2A):965-71.
106. Jeymesson RCV, Ivone AS, Silene CN, Sonia PL. Indigofera suffruticosa: An alternative anticancer therapy, eCAM 2007;4(3):355-9.
107. Seifert G, Jesse P, Laengler A, et al. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett. 2008; 264:218-28.
108. Guillermina B, Noelia L, Lorena P, Aldo RE, Juan JC, Marta EG. In vitro antitumoral activity determination of native plant extracts of the central region of Argentina. Mol Med Chem. 2006; 10: 22-3.
109. Yazdanparast R, Sadeghi H. Antineoplastic effects of Daphne mucronata: inhibition of DNA and RNA synthesis. Acta Medica Iranica, 2003; 41(4): 202-6.
110. Geeta C, Mali RS, Pradeep KG. Chemopreventive potential of Aloe vera against 7, 12-dimethylbenz(a)anthracene induced skin papillomagenesis in mice, Integr Cancer Ther. 2007; 6: 405-9.
111. Abu-Dahab R, Fatma A. Antiproliferative activity of selected medicinal plants of Jordan against a breast adenocarcinoma cell line MCF7. Sci. Pharm. 2007; 75: 121-36.
112. Akbar MA, Rubina A, Khondoker DA, Ali MS. In vitro cytotoxic properties of ethanolic extracts of various parts of Swietenia mahagoni. Euro J Sci Res. 2009; 32(4): 541-4.
113. Gupta M, Mazumder UK, Haldar PK, Kandar CC, Laxmanan M, Senthil GP. Anticancer activity of Indigofera aspalathoides andWedelia calendulaceae in swiss albino mice. Iran J Pharmac Res. 2007; 6 (2): 141-5.
114. Noriko Y, Erika K, Satomi K, Kazumasa S, Masaru K, Kazuki N. Effect of Cordyceps sinensis on spontaneous metastatic model mice. Anticancer Res. 2008; 28: 3157-3556.
115. Xue X, Peng B, Tri M, et al. The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway. Mol Cancer Ther. 2009; 8(5): 1179-88.
116. EB. Discovery of water-soluble anticancer agents from a vegetable found in Benin City, Nigeria. Exp Biol Med 2003; 228(3): 293-8.
117. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med 2002; 227(1): 20-25.
118. Adrienne CS, Krya P, Nicole CH, Clark WD. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complementary and Alternative Medicine. 2006; 6: 27.
119. Sathishkumar J, Muthusaravanan M, Seethalakshmi I. In vitro antimicrobial and antitumor activities of Stevia rebaudiana (asteraceae) leaf extracts. Tropical J Pharmaceut Res 2008; 7 (4): 1143-9.
120. Chu Q, Satoh K, Kanamoto T, et al. Antitumor potential of three herbal extracts against human oral squamous cell lines. Anticancer Res 2009; 29(8): 3211-9.
121. JW. Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 2003; 78: 579S-83S
122. Wargovich MJ, Woods C, Hollis DM, Zander ME. Herbals, Cancer Prevention and Health. Available at jn.nutrition.org (Accessed on November 16, 2009). International Research Conference on Food, Nutrition, and Cancer, Washington DC, July 15-16, 2004.
123. Madhuri S, Govind P. Some anticancer medicinal plants of foreign origin, Current Sci 2009; 96(6): 779-83.
124. Lakshmi KS, Sharma SS, Rajesh T, Chitra V. Antitumour activity of ethanolic extract of leaves of Holoptelea integrifolia on Dalton's ascitic lymphoma in Swiss albino mice. Int J Green Pharm 2010; 4:44-7.
125. Kwon HJ, Bae S, Kim KH, et al. Induction of apoptosis in HeLa cells by ethanolic extract of Corallina pilulifera, Food Chem 2007; 104:196-201.
126. Kwon HJ, Hong YK, Kim KH, et al. Methanolic extract of Pterocarpus santalinus induces apoptosis in HeLa cells. J Ethnopharmacol 2006; 105: 229-34.
127. Mohan S, Ahmad BA, Siddig IA, et al. Typhonium flagelliforme induces apoptosis in CEMss cells via activation of caspase-9, PARP cleavage and cytochrome c release: Its activation coupled with G0/G1 phase cell cycle arrest. J Ethnopharmacol 2010; 132: 592-600.